Compositions for treating viral infections and methods for same
Compositions containing a protease inhibitor for treating viral infections and methods for treating a patient before, during, or after exposure to an infectious agent by administering such compositions are described herein.
1. A method for treating COVID-19 infection comprising administering to a subject in need of treatment a composition selected from the group consisting of polylysine, α-polylysine, and ε-polylysine and a pharmaceutically acceptable carrier.
2. The method of claim 1 , wherein administering is carried out by topical administration to an eye, ear, or nose of the subject.
3. The method of claim 1 , wherein administering is carried out by intranasal spray.
4. The method of claim 1 , further comprising repeating administering at least once per day.
5. The method of claim 1 , wherein administering reduces viral load in patient sputum or blood plasma by at least about 20%.
6. The method of claim 1 , wherein administering improves time to recovery by at least about 20%.
7. The method of claim 1 , wherein administering reduces long term effects of COVID-19.
8. The method of claim 1 , wherein the polylysine, α-polylysine, and ε-polylysine comprises an amino acid sequence selected from the group consisting of RGRR (SEQ ID NO:1), RKRKKR (SEQ ID NO:2), RKKR (SEQ ID NO:3), RRRKKR (SEQ ID NO:4), and combinations thereof.
9. The method of claim 1 , wherein the composition further comprises an antiviral agent or anti-inflammatory agent.
10. The method of claim 1 , further comprising administering an antiviral agent or an anti-inflammatory agent with the composition.
11. The method of claim 10 , wherein administering the antiviral agent on anti-inflammatory agent is carried out simultaneously or sequentially with the composition.
12. The method of claim 10 , wherein administering the antiviral agent or anti-inflammatory agent is carried out by oral administration or injection.